ARTERIAL DILATIVE

FEVAR COOK

Introduction

Last updated: apr 5, 2023

A standard EVAR procedure is not feasible for patients with juxtarenal or pararenal aneurysms. For patients with an acceptable life expectancy (≥ 2 years) but for whom open repair is undesirable due to comorbidities, previous surgeries in the operative area, or other reasons, a fenestrated EVAR (FEVAR) may be the appropriate treatment. No randomized studies are available comparing FEVAR with open repair.
FEVAR may involve several specific complications in addition to those associated with standard EVAR, requiring attention:

  • Occlusion of visceral vessels (renal artery, superior mesenteric artery, celiac trunk)
  • Malposition/improper deployment of visceral stents
  • Type 3 endoleak via fenestrations/branches
  • Spinal ischemia <2% (spinal cord injury [SCI])
  • Stroke <2% (especially with access via the arm)

Ideally, treatment should take place in a hybrid OR, as this has been shown to reduce radiation exposure, contrast use, and procedure time (partly due to fusion techniques). Additionally, cone-beam CT allows immediate assessment of results and the correct positioning and deployment of stents.
Other methods to save time, contrast, and/or radiation include:

  • Adequate planning with pre-determined optimal angles per target vessel
  • Minimizing radiation (7.5 frames/sec is generally sufficient)
  • Limiting digital subtraction angiography as much as possible

Protection measures for the treatment team: Lead apron, shields, thyroid protection, lead glasses, maintaining distance when possible, and avoiding unnecessary radiation exposure.

 

Presentation

File NameTypePermissionsChanged DateDateSize

 

Indications

Inclusion Criteria for FEVAR

  • Juxta- or pararenal aneurysm (thoracoabdominal aneurysms are not treated at our center)
  • Infrarenal neck of at least 4 mm
  • Patent ostia of renal arteries (4-8 mm), SMA, and celiac trunk (6-10 mm)
  • ZFEN requires at least 15 mm proximal sealing zone – small fenestration
  • >12 mm from the proximal edge and necessary SMA scallop
  • Supra- and/or infrarenal angulation <45 degrees
  • Iliac diameter ≥9 mm ipsilateral, ≥7 mm contralateral

These dimensions primarily apply to the COOK Zenith Fenestrated (ZFER). Custom-made devices allow more flexibility regarding diameter and target vessel positioning.

 

Contra indications

Absolute

  • Multiple small renal arteries or early bifurcation of the renal artery
  • Severe angulation (> 45 degrees)
  • Shaggy aorta
  • Inadequate access (minimum 7-8 mm)

Relative

Consider planning proximal sealing further upstream if it does not lead to overstenting of extra-lumbar/intercostal arteries, improving long-term outcomes.

My Image
My Image
My Image

Overweeg verder naar proximaal plannen sealing als dit niet tot overstenten extra lumbalen / intercostalen lijdt voor betere lange termijn uitkomst.

 

Workup

A CTA thorax-abdomen must be performed. If only a CTA abdomen is available, an additional CTA thorax (including proximal carotid and left subclavian artery imaging) is required.
Length measurements:

  • Proximal – center of each visceral branch
  • Proximal – aortoiliac bifurcation
  • Proximal – iliac bifurcation
  • Landing zone length for target vessels
Diameter measurements:
  • Aorta (proximal, at fenestrations, aortoiliac bifurcation)
  • Visceral target vessels
  • Iliac and femoral access
  • Diameter of IMA and lumbar arteries to be overstented
Clock positions and corresponding C-arm angles for imaging:
  • Each visceral origin
  • Lumbar arteries
Other considerations:
  • Adequate proximal sealing – if it does not require overstenting extra-lumbar arteries, consider extending the sealing zone proximally.
  • 4-fenestration vs. 2-fenestration configurations: Longer, healthy sealing zones improve long-term outcomes. If disease progression occurs, there is a risk of stent migration and kinking in target vessels.
  • Avoid brachial access if possible (higher complication risk and increased radiation exposure for the operator).

 

Pre procedural

  • Discontinue clopidogrel perioperatively and switch to aspirin in case spinal drainage is required.
  • Ensure 2 cross-matched blood units are available.
  • Confirm sedation team availability.
  • Hemoglobin >6 mmol/L – correct if lower.
  • Patient admission fasting on the day of surgery.
  • Antibiotic prophylaxis: Cefazolin 2000 mg IV once, repeat 1000 mg if procedure >4 hours, continue for 24 hours (3x 1000 mg/day).
  • Urinary catheter placement.
  • No prophylactic cerebrospinal fluid drainage.
  • Monitor connection (ECG, BP).
  • Ensure two functional IV lines
  • 2000 mg Kefzol
  • Check anticoagulation
  • Check allergies
  • Imaging and EVAR measurement on wall/monitor
  • Check ordered grafts tents

 

Materials

Essentials

  • Chlorhexidine
  • Standard angiography set
  • Lidocaine 10 ml x 2
  • Bupivacaine 10 ml x 2
  • Contrast
  • Heparinized saline and flushing syringes
  • 6F Introducer x 2
Wires
  • Terumo wire 260
  • 2x Lunderquist 260
  • Rosen wire per renal artery
  • Amplatz short DP for SMA/celiac trunk
Sheaths
  • 7F, 55 cm (1 per fenestration)
  • 20F guiding sheath (for 7F sheaths to pass through)
  • Use 22F for 4-fenestration cases
Balloons
  • CODA balloon
  • PTA balloon (flare balloon)
Endografts
  • ZFER
  • Zenith Flex bifurcation
  • Ipsilateral and contralateral leg components
Closure
  • Manta 14F (up to 14F)
  • Manta 18F (15-20F)

Non-Essentials

Workflow
File NameTypePermissionsChanged DateDateSize

 

Positioning the patient

  • Supine position, arms behind the head or alongside the body (2 fenestrations).
  • Skin disinfection and exposure of the groin, abdomen from xiphoid to symphysis, and axillary/brachial region.
  • Anesthesia position: head end on the right side.
  • C-arm and monitor position: left side of the patient.
  • Team position: right side of the patient (assistant may be opposite the operator).

Powerpoint
File NameTypePermissionsChanged DateDateSize

 

The procedure in steps

Preparation

  • TOP
  • Antibiotics
  • Imaging and EVAR measurements on the monitor
  • Check prostheses
  • Position the patient: table cranially, left arm alongside the body, peripheral pulses
  • Drape according to protocol
  • Pressure line to syringe pump and flush
Access
  • Local anesthesia in the groin
  • Ultrasound-guided puncture of the CFA, measure for Manta closure device and place 7Fr sheaths
  • 5000 IU heparin, repeat 2500 IU every hour
Deployment and Unfolding of the Fenestrated Body of the Endograft
Main side
  • Insert stiff guidewire via Terumo/angiocatheter on the main side
  • Check markers outside the patient
Ipsilateral Side
  • Insert fenestrated endoprosthesis (ZFEN) ipsilaterally
  • Perform angiography to visualize renal arteries from the contralateral side
  • Check markers (in AP position, optionally cranio-caudal, proximal, fenestrations, anterior/posterior, tick marker, and distal) (Figure 3)
  • Partially deploy ZFEN to "diamond shape" and check fenestrations, then continue deployment
Renal Artery Cannulation and Stent Placement
  • Engage the prosthesis from the left, insert Terumo guidewire with catheter into the graft
  • Exchange catheter over stiff guidewire for a 20F sheath within the graft
  • Puncture this sheath (eccentrically) and insert two short 7F sheaths
  • Engage renal artery with Terumo/catheter (e.g., Berenstein), place Rosen wire via the catheter
  • Advance a long 7F sheath (ANL) over it
  • Engage the other renal artery
  • Replace short sheath and catheter on this side as well with a long 7F sheath into the renal artery
  • Advance stents into the renal arteries via the 7Fr sheaths
  • Fully deploy ZFEN (reducing ties) and top stent after retracting angiocatheter
  • Release stent from delivery device and retrieve top cap
  • Balloon dilation with Coda balloon
  • Align renal artery (markers in line) and retract 7Fr sheath
  • Place stents in the sheaths, then retract the sheaths
  • Deploy stent and flare with tip PTA balloon (10 or 12 mm)
  • Repeat for the other renal artery
  • Reintroduce sheaths into renal arteries and perform bilateral angiography with apnea; check aneurysm filling from renal arteries
  • Remove both renal artery guidewires and 7F sheaths
Bifurcated Graft Placement
  • Replace main sheath with bifurcation prosthesis
  • Maximum proximal marker height just below the bifurcation
  • Deploy with contralateral limb above aortic bifurcation
  • Engage contralateral limb and open the top of the bifurcation
  • Insert Lunderquist
  • Place contralateral limb according to standard EVAR procedure
  • Complete ipsilateral limb and remove delivery device according to standard EVAR procedure
  • Withdraw sheaths distally to the CIA bilaterally and perform ballooning (cuff overlap, not above bifurcation, and CIA bilaterally)
Final Angiographic Assessment
  • Perform control angiogram, long series, to assess potential endoleak and patency of renal arteries and CIAs
Closure
  • Remove devices/sheaths/catheters
  • Hemostasis with Manta device bilaterally
  • SOP

 

Tips and tricks

  • When attaching the limb, it is possible to catheterize the cuff instead of the limb. To check this, place the catheter high in the roof of the bifurcated graft (which is still "closed"). If the catheter then bends back, it indicates that you are in the limb. An additional check is that when pulling back the black trigger wire, the catheter "pops" up.
  • If you are still unsure, you can insert a Coda balloon and inflate it proximally in the limb, creating a "mushroom" shape.

 

Complications

Spinal Cord Ischemia (SCI)
A serious but uncommon complication after FEVAR (<2%). The risk increases when a larger portion of the aorta is covered (including lumbar and intercostal arteries), after previous aortic surgery, or in cases of occlusion of important collateral arteries supplying the spinal cord, such as the left subclavian artery and the internal iliac arteries. Significant blood loss is also a risk factor for SCI. In a large series of over 200 patients, no cases of SCI were observed in patients with a sealing zone <4 cm proximal to the celiac trunk (Juszczak 2019).

Management of SCI (Scali 2018):

  • Transfer the patient to ICU/MC
  • Target blood pressure: MAP 90–100 mmHg
  • Initiate spinal fluid drainage (<1 hour; see below)
  • Target hemoglobin >6 g/dL
  • Methylprednisolone (hydrocortisone/dexamethasone also acceptable?) 1000 mg IV over 30 minutes (to reduce edema)
  • Mannitol 12.5 g IV over 15 minutes
  • Naloxone 1–1.5 mcg/kg/hour IV
  • Avoid morphine (due to spinal cord metabolism), use fentanyl if pain relief is needed
  • Involve ICU neurology team

Spinal Fluid Drainage
  • Draining spinal fluid lowers resistance to spinal cord perfusion according to the formula:
  • Spinal Cord Perfusion Pressure = Blood Pressure – Cerebrospinal Fluid Pressure**
  • In other words, by reducing cerebrospinal fluid pressure, spinal cord perfusion improves (see Figure 4).

Drainage Monitoring:
  • Insert a spinal drain using a 16G Tuohy needle
  • Set the drain at 10 cm H₂O after placement
  • If symptoms persist, lower to 5 mmHg (caution: do not drain more than 30 mL/hour)
  • Warning: Rapid or excessive drainage may rupture anchoring veins, causing severe intracerebral hemorrhage
  • Strict bed rest, avoid elevating the head to prevent increased drainage
  • Check drain positioning every 4 hours
  • If headache occurs, reduce drainage if the neurological status allows
  • Keep the drain in place for 48 hours, then remove unless symptoms reappear after closure
  • If bloody fluid drains, stop drainage temporarily, consult neurology, and perform CT brain or MRI myelography to rule out bleeding

Risks of Spinal Fluid Drainage
  • Complications include subarachnoid hemorrhage (SAH), spinal hematoma, stroke (bleeding), paresthesia during drainage, reflex hypotension, bloody cerebrospinal fluid, drain dysfunction, or infection. Prophylactic drainage is generally not performed except in high-risk patients, such as those with:
  • Thoracic stenting >200 mm
  • Stenting at T8–T12
  • Extensive previous abdominal aortic surgery or TEVAR
  • Chronic kidney failure, anemia, or perioperative MAP <70 mmHg, which may also contribute to spinal ischemia

Other Complications
  • Suspected visceral stent occlusion Urgent CT-Angio and consult vascular surgery
  • Endoleak around fenestrations (Type 3) Reintervention to restore seal
  • Other complications** similar to standard EVAR (see AAA – Endovascular Treatment (EVAR))

Endoleaks

  • Occurrence: 8–45%
  • 40–67% managed conservatively
  • Aneurysm growth <5% is present in 1% of ruptures
  • Presence of two lumbar arteries at L3 or L4** or an IMA correlates with a higher risk of endoleak, with IMA posing a greater risk than lumbar arteries
  • IMA diameter >2 mm 46–67% chance of endoleak
1 2

Sac regression

Sac regression is correlated to improved survival and a reduced rate of secondary interventions and EVAR-related complications. The prognostic significance of sac regression should be considered in surveillance strategies. Intensified surveillance should be applied in patients who fail to achieve sac regression following EVAR.

TLA Technique:

Embolization of the sac versus sac and branches shows no difference in outcomes.
3

Laser-Assisted Transgraft Embolization

Successful embolization was achieved with aneurysmal sac regression demonstrated on 1-year follow-up CT angiography.

Martini Pre-EVAR Embolization Criteria:

  • IMA ≥ 2.5 mm
  • IMA open AND one or more lumbar arteries ≥ 2 mm at origin
  • IMA open and an AAA of aorta AND AIC

  1. O'Connor, P. J., & Lookstein, R. A. (2015, September). Predictive factors for the development of type 2 endoleak following endovascular aneurysm repair. Seminars in interventional radiology. Retrieved April 27, 2023, from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4540615/

  2. Aoki, A., Maruta, K., Hosaka, N., Omoto, T., Masuda, T., & Gokan, T. (2017, December 25). Evaluation and coil embolization of the aortic side branches for prevention of type II endoleak after endovascular repair of abdominal aortic aneurysm. Annals of vascular diseases. Retrieved April 27, 2023, from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835439/

  3. Yu, H., Al-Roubaie, M., Desai, H., Isaacson, A., & Burke, C. (2017). Comparison of type II endoleak embolizations: Embolization of Endoleak Nidus only versus embolization of endoleak nidus and branch vessels. Journal of Vascular and Interventional Radiology, 28(2). https://doi.org/10.1016/j.jvir.2016.12.1019

 

Post-op

Day of Procedure:

  • Postoperative observation in IC/MC
  • Hourly neurological checks of the legs (lifting both legs off the bed)
  • Target systolic BP: 120–150 mmHg (MAP >80)
  • Puncture sites covered with dressings
  • 4 hours of bed rest (due to closure device), avoiding hip, abdominal, and neck flexion to prevent pressure on the groin
  • Extended bed rest and SPICA dressing if indicated (e.g., minor ongoing bleeding despite proper closure device use)
  • Early mobilization after initial short immobilization
  • Unrestricted diet, IV fluids as needed
Postoperative Day 1:
  • Check groins for swelling and pulsations
  • Lab tests: Hb, Creatinine
  • Discharge if no complications

 

Follow-up

Pre-Discharge and Follow-Up Plan

  • Pre-discharge CTA (CT angiography)
  • 6-week follow-up with the operating surgeon, including a CTA, to be discussed in the vascular meeting
  • Annual follow-up CTA
Management of Endoleaks and Complications
  • Type 1 or 3 endoleak on first postoperative CTA Refer to vascular meeting and plan reintervention
  • Type 2 endoleak without aneurysm growth Conservative management
  • Type 2 endoleak with aneurysm growth (≥5 mm in 1 year) Refer to vascular meeting and plan reintervention
  • Target vessel occlusion or stenosis Refer to vascular meeting
Medication Check and Secondary Prevention
  • Verify if the patient is on antiplatelet therapy or anticoagulation and a statin
  • If not prescribed, initiate:
  • Clopidogrel 75 mg once daily
  • Atorvastatin 40 mg once daily

 

Report

TOP Time-out procedure. Antibiotica profylaxe. Sedatie + lokale anesthesie beide liezen middels levobupivacaïne 0,5% en lidocaïne 1%. Echogeleide punctie AFC bdz, meten voor Manta device, waarna plaatsen 7Fr sheath. 5000 EH heparine .

Main zijde inbrengen stijve voerdraad, via terumo/angiocatheter. Buiten de patient markers controleren van de prothese. Ipsilateraal inbrengen gefenestreerde endoprothese (ZFEN-P-2-30-124). Angiografie met afbeelden nierarteriën via de andere kant. Controleer markersen positioneren stent. Deels ontplooien ZFEN tot “diamond shape” en controle fenestraties, daarna verder ontplooien ZFEN.

Aanhaken van de prothese via links, inbrengen terumo voerdraad met catheter tot in de graft. Over stijve voordraad vervangen van de catheter voor een 20F sheath binnen de graft. Aanprikken van deze sheet (excentrisch) met inbrengen van 2 korte 7F sheaths. Aanhaken nierarterie metcobra catheter, via catheter plaatsen Rosenwire. Hierover een lange 7F sheath (ANL). Aanhaken van de andere nierarterie Ook aan deze kant de korte sheath en katheter vervangen door een lange 7F sheath tot in de nierarterie. Opvoeren stents in nierarterieen via de 7F sheats.

Volledig ontplooien ZFEN (reducing ties) en topstent na terugtrekken angiocatheter. Release stent van delivery device en ophalen topcap. Balloneren met Coda ballon. Uitdraaien nierarterie (markers op 1 lijn) en terugtrekken 7Fr sheath. Plaatsen van de stents, eerst rechts (BGP2806). Flaren met tip van de PTA ballon (10/20 mm). Nu plaatsen linker nierarteriestent (BGP3707). Ook hier flaren van de stent met dezelfde PTA ballon. Weer opvoeren van sheats in de nierarterie bdz. Via deze angio met apneu. Geen aanwijzingen voor lekkage naar het aneurysma. Verwijderen beide nierarterie voerdraden en 7F sheaths.

Main sheath vervangen door bifurcatieprothese (UNIBODY-24-98). Maximale hoogte proximale markers net onder het kruis. Ontplooien met contralaterale pootje boven de aortabifurcatie. Aanhaken contralaterale pootje. Positiecontrole met Codaballon proximaal in het pootje. Openen top van de bifurcatie. Plaatsen Lunderquist. Plaatsen contralaterale poot (ZISL-13-125) conform standaard EVAR procedure. Ipsilaterale poot afmaken en verwijderen delivery device conform standaard EVAR procedure. Verlenging (ZISL-20-77).

Terugtrekken sheaths tot distaal van de AIC bdz en ballonneren (cuff overlap, niet boven kruis, en AIC bdz).

Controle angiogram, lange serie, geen aanwijzingen voor endoleak met doorgankelijke nierarteriën en AIC rechts.

Verwijderen devices / sheaths / katheters Hemostase met Manta device bdz. SOP

 

Literature

File NameTypePermissionsChanged DateDateSize

  • ESVS 2019 Clinical Practice Guidelines on the Management of Abdominal Aorto-iliac Artery Aneurysms
  • https://www.ncbi.nlm.nih.gov/pubmed/30528142
  • Mayo Clinics: FEVAR / BEVAR Tips and Tricks: From Sizing to Implantation and Evaluation
  • https://www.youtube.com/watch?v=CokJFzqKMPE
  • Scali ST, Kim M, Kubilis P,et al. Implementation of a bundled protocol significantly reduces risk of spinal cord ischemia after branched or fenestrated endovascular aortic repair. J Vasc Surg. 2018 Feb;67(2):409-423.e4.
  • https://www.ncbi.nlm.nih.gov/pubmed/29017806/
  • Kitpanit N, Ellozy SH, Connolly PH, et al. Risk factors for spinal cord injury and complications of cerebrospinal fluid drainage in patients undergoing fenestrated and branched endovascular aneurysm repair. J Vasc Surg. 2021 Feb;73(2):399-409.e1.
  • https://pubmed.ncbi.nlm.nih.gov/32640318/
  • Juszczak MT, Murray A, Koutsoumpelis A, et al. Elective Fenestrated and Branched Endovascular Thoraco-abdominal Aortic Repair with Supracoeliac Sealing Zones and without Prophylactic Cerebrospinal Fluid Drainage: Early and Medium-term Outcomes. Eur J Vasc Endovasc Surg. 2019 May;57(5):639-648.
  • https://pubmed.ncbi.nlm.nih.gov/31005508/

  1. J. Mark Ryan, MD, S. M. Key, Siobhan A. Dumbleton, MD, and Tony P. Smith, MD Nonlocalized Lower Gastrointestinal Bleeding: Provocative Bleeding Studies with Intraarterial tPA, Heparin, and Tolazoline J Vasc Interv Radiol 2001 Nov;12(11):1273-7

  2. Baum ST. Arteriographic diagnosis and treatment of gastrointestinal bleeding. In Baum ST, Pentecost MJ, eds. Abrams' angiography interventional radiology. 2nd ed. Philadelphia, Pa:Lippincott, Williams & Wilkins, 2006:488.

  3. Poultsides GA, Kim CJ, Orlando R 3rd, et al. Angiographic embolization for gastroduodenal hemorrhage: safety, efficacy, and predictors of outcome. Arch Surg. 2008;143:457-461.

  4. Eriksson LG, Sundbom M, Gustavsson S, Nyman R. Endoscopic marking with a metallic clip facilitates transcatheter arterial embolization in upper peptic ulcer bleeding. J Vasc Interv Radiol. 2006;17:959-964.

  5. Dixon S, Chan V, Shrivastava V et al. Is there a role for empiric gastroduodenal artery embolization in the management of patients with active upper GI hemorrhage? Cardiovasc Intervent Radiol. 2013 Aug;36(4):970-7.

  6. Shin JH. Recent update of embolization of upper gastrointestinal tract bleeding. Korean J Radiol 2012;13 Suppl 1:S31-S39.

  7. van Leerdam ME. Epidemiology of acute upper gastrointestinal bleeding. Best Pract Res Clin Gastroenterol. 2008;22(2):209-24.

  8. Sildiroglu O, Muasher J, Arslan B, Sabri SS, Saad WE, Angle JF, Matsumoto AH, Turba UC. Outcomes of patients with acute upper gastrointestinal nonvariceal hemorrhage referred to interventional radiology for potential embolotherapy. J Clin Gastroenterol. 2014;48(8):687-92.

  9. Strate LL, Gralnek IM. ACG Clinical Guideline: Management of Patients With Acute Lower Gastrointestinal Bleeding. Am J Gastroenterol. 2016 Apr;111(4):459-74.

  10. van Dam J, Brugge WR. Endoscopy of the upper gastrointestinal tract. N Engl J Med. 1999;341(23):1738-48.

  11. Lefkovitz Z, Cappell MS, Lookstein R, Mitty HA, Gerard PS. Radiologic diagnosis and treatment of gastrointestinal hemorrhage and ischemia. Med Clin North Am. 2002 Nov;86(6):1357-99.

  12. Lee EW, Laberge JM. Differential diagnosis of gastrointestinal bleeding. Tech Vasc Interv Radiol 2004; 7: 112-22

  13. Strate LL, Gralnek IM. ACG Clinical Guideline: Management of Patients With Acute Lower Gastrointestinal Bleeding. Am J Gastroenterol. 2016 Apr;111(4):459-74.

  14. Chaudhry V, Hyser MJ, Gracias VH, Gau FC. Colonoscopy: the initial test for acute lower gastrointestinal bleeding. Am Surg. 1998 Aug;64(8):723-8.

  15. Cummings CL. Value of early capsular endoscopy for severe gastrointestinal bleeding. J Natl Med Assoc. 2004;96(12):1653-6.

  16. Appleyard M, Glukhovsky A, Swain P. Wireless-capsule diagnostic endoscopy for recurrent small-bowel bleeding. N Engl J Med. 2001;344(3):232-3.

  17. Lim JK, Ahmed A. Endoscopic approach to the treatment of gastrointestinal bleeding. Tech Vasc Interv Radiol. 2004 Sep;7(3):123-9.

  18. Nicholson AA, Ettles DF, Hartley JE, et al. Transcatheter coil embolotherapy: a safe and effective option for major colonic haemorrhage. Gut 1998; 43:79–84.

  19. Zuckier LS. Acute gastrointestinal bleeding. Semin Nucl Med. 2003 Oct;33(4):297-311.

  20. Imbembo AL, Diverticular disease of the colon. In: Sabiston D, Editor. Textbook of Surgery (14th edn). Philadelphia, PA:WB Saunders, 1992:910.

  21. Loffroy R, Rao P, Ota S, De Lin M, Kwak BK, Geschwind JF. Embolization of acute nonvariceal upper gastrointestinal hemorrhage resistant to endoscopic treatment: results and predictors of recurrent bleeding. Cardiovasc Intervent Radiol. 2010 Dec;33(6):1088-100. doi: 10.1007/s00270-010-9829-7. Epub 2010 Mar 16.

  22. Eriksson LG, Sundbom M, Gustavsson S, Nyman R. Endoscopic marking with a metallic clip facilitates transcatheter arterial embolization in upper peptic ulcer bleeding. J Vasc Interv Radiol. 2006 Jun;17(6):959-64.

  23. Anthony S, Milburn S, Uberoi R. Multi-detector CT: review of its use in acute GI haemorrhage. Clin Radiol. 2007 Oct;62(10):938-49.

  24. Ernst O, Bulois P, Saint-Drenant S, Leroy C, Paris JC, Sergent G. Helical CT in acute lower gastrointestinal bleeding. Eur Radiol. 2003;13(1):114-7

  25. Mirsadraee S, Tirukonda P, Nicholson A, Everett SM, McPherson SJ. Embolization for non-variceal upper gastrointestinal tract haemorrhage: a systematic review. Clin Radiol 2011;66:500-509.

  26. Loffroy R, Guiu B, D'Athis P, Mezzetta L, Gagnaire A, Jouve JL, Ortega-Deballon P, Cheynel N, Cercueil JP, Krausé D. Arterial embolotherapy for endoscopically unmanageable acute gastroduodenal hemorrhage: predictors of early rebleeding. Clin Gastroenterol Hepatol. 2009 May;7(5):515-23.

  27. Aina R, Oliva VL, Therasse E, et al. Arterial embolotherapy for upper gastrointestinal hemorrhage: outcome assessment. J Vasc Interv Radiol 2001;12:195-200.

  28. Mirsadraee S, Tirukonda P, Nicholson A, Everett SM, McPherson SJ. Embolization for non-variceal upper gastrointestinal tract haemorrhage: a systematic review. Clin Radiol 2011;66:500-509.

  29. Loffroy R, Guiu B, Cercueil JP, Lepage C, Latournerie M, Hillon P, Rat P, Ricolfi F, Krausé D. Refractory bleeding from gastroduodenal ulcers: arterial embolization in high-operative-risk patients. J Clin Gastroenterol. 2008 Apr;42(4):361-7.

  30. Loffroy R, Guiu B, D'Athis P, Mezzetta L, Gagnaire A, Jouve JL, Ortega-Deballon P, Cheynel N, Cercueil JP, Krausé D. Arterial embolotherapy for endoscopically unmanageable acute gastroduodenal hemorrhage: predictors of early rebleeding. Clin Gastroenterol Hepatol. 2009 May;7(5):515-23.

  31. Poultsides GA, Kim CJ, Orlando R 3rd, Peros G, Hallisey MJ, Vignati PV. Angiographic embolization for gastroduodenal hemorrhage: safety, efficacy, and predictors of outcome. Arch Surg 2008;143:457-461.

  32. Gordon RL, Ahl KL, Kerlan RK, Wilson MW, LaBerge JM, Sandhu JS, Ring EJ, Welton ML. Selective arterial embolization for the control of lower gastrointestinal bleeding. Am J Surg. 1997;174(1):24-8.

  33. Funaki B, Kostelic JK, Lorenz J, Ha TV, Yip DL, Rosenblum JD, et al. Superselective microcoil embolization of colonic hemorrhage. AJR Am J Roentgenol 2001;177:829-836 7.

  34. Bandi R, Shetty PC, Sharma RP, Burke TH, Burke MW, Kastan D. Superselective arterial embolization for the treatment of lower gastrointestinal hemorrhage. J Vasc Interv Radiol 2001;12:1399-1405.

  35. Maleux G, Roeflaer F, Heye S, Vandersmissen J, Vliegen AS, Demedts I, et al. Long-term outcome of transcatheter embolotherapy for acute lower gastrointestinal hemorrhage. Am J Gastroenterol 2009;104:2042-2046

  36. Leitman IM, Paull DE, Shires GT 3rd. Evaluation and management of massive lower gastrointestinal hemorrhage. Ann Surg 1989;209:175-180

  37. Rosenkrantz H, Bookstein JJ, Rosen RJ, Goff WB 2nd, Healy JF. Postembolic colonic infarction. Radiology 1982;142:47-51.

  38. Koh DC, Luchtefeld MA, Kim DG, Knox MF, Fedeson BC, Vanerp JS, et al. Efficacy of transarterial embolization as definitive treatment in lower gastrointestinal bleeding. Colorectal Dis 2009;11:53-59

  39. Lipof T, Sardella WV, Bartus CM, Johnson KH, Vignati PV, Cohen JL. The efficacy and durability of super-selective embolization in the treatment of lower gastrointestinal bleeding. Dis Colon Rectum 2008;51:301-305

DISCLAIMER

The information contained herein has been obtained from sources believed to be reliable. However, no warranty as to the accuracy, completeness or adequacy of such information is implied. No liability is accepted for errors, omissions or inadequacies in the information contained herein or for interpretations thereof. The reader assumes sole responsibility for the selection of these materials to achieve its intended results. The opinions expressed herein are subject to change without notice.

Thank you! ×
Opps! Some went wrong... Your submission did not go through :-(×
Stacks Image 14

WEBDESIGN

Stacks Image 20

PHOTOGRAPHY

Stacks Image 26

E-COMMERCE

Stacks Image 32

SEO

Stacks Image 38

COLORS

Stacks Image 44

CRM

EXCELLENCE IS NOT A SKILL, IT'S AN ATTITTUDE

WEBDESIGN - PHOTOGRAPHY - GRAVENDEEL